Annual Report 2010 - Hannover Re
Annual Report 2010 - Hannover Re
Annual Report 2010 - Hannover Re
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
13 October <strong>2010</strong> that taxation of foreign sourced investment<br />
income recorded by Irish subsidiaries was not permissible, we<br />
were able to release provisions that had been constituted in<br />
this regard. The core of the legal dispute revolved around the<br />
question of whether investment income generated by a reinsurance<br />
subsidiary based in Ireland was subject to taxation at<br />
the parent company in Germany. The ruling of the BFH confirmed<br />
the decision in the first instance of the Lower Saxony<br />
Fiscal Court in <strong>Hannover</strong>. Against this backdrop, all tax risks<br />
were reassessed. This resulted in an increase of altogether<br />
EUR 112.2 million in Group net income.<br />
In December <strong>2010</strong> we reached agreement on the sale of all<br />
operational companies of our US subsidiary Clarendon Insurance<br />
Group, Inc., New York, to the Bermuda-based Enstar<br />
Group Ltd., Hamilton. The transaction, which is still subject to<br />
the customary foreign regulatory approvals, is expected to<br />
close in the second quarter of 2011. The purchase price of<br />
Clarendon, which has been in run-off since 2005, is equivalent<br />
to EUR 162.5 million before final price determination. The sale<br />
enables us to reduce material risks for our company, including<br />
for example those connected with reinsurance recoverables<br />
on unpaid claims. We are also able to eliminate operational<br />
risks associated with the run-off of a US primary insurer as<br />
well as considerable administrative expenses that would have<br />
been incurred in subsequent years. In accordance with IFRS<br />
accounting practice, the sale of Clarendon produces a charge<br />
of EUR 69.2 million to our Group net income in the year under<br />
review, which is recognised in the non-life reinsurance business<br />
group.<br />
The operating profit (EBIT) booked by <strong>Hannover</strong> <strong>Re</strong> increased<br />
to EUR 1.2 billion (EUR 1.1 billion) in <strong>2010</strong>. The previous year<br />
had been influenced by positive special effects in life and<br />
health reinsurance amounting to EUR 144.7 million. These<br />
derived from the acquisition of the ING life reinsurance portfolio<br />
as well as the reversal of unrealised losses on deposits<br />
held by US cedants on behalf of <strong>Hannover</strong> <strong>Re</strong> (ModCo). The<br />
Group net income of EUR 748.9 million once again surpassed<br />
the outstanding level of the previous year (EUR 733.7 million).<br />
A very healthy underlying operating profit and favourable nonrecurring<br />
effects associated with the decision of the Federal<br />
Fiscal Court were both factors in this positive performance.<br />
Earnings per share amounted to EUR 6.21 (EUR 6.08).<br />
Our shareholders’ equity excluding minority interests also developed<br />
particularly favourably, rising in the year under review<br />
from EUR 3.7 billion to EUR 4.5 billion. The policyholders’<br />
surplus increased from EUR 5.6 billion to EUR 7.0 billion. The<br />
return on equity for <strong>2010</strong> came in at 18.2%.<br />
In September <strong>2010</strong> we used the relatively low interest rate<br />
level to place subordinated hybrid debt of EUR 500 million on<br />
the European capital market. The bond, which has a term of<br />
30 years, serves to further optimise our capital structure as<br />
well as to back future growth with the necessary capital resources.<br />
We use retrocession, i.e. the passing on of portions of our<br />
covered risks to other reinsurers, as a means of risk reduction.<br />
In the course of the year the reinsurance recoverables on unpaid<br />
claims – i.e. receivables due to us from our retrocessionaires<br />
– decreased to EUR 1.0 billion (EUR 1.7 billion). Of this<br />
total reduction, an amount of EUR 0.8 billion results from the<br />
sale of Clarendon. We continue to attach considerable importance<br />
to the quality of our retrocessionaires: 92.4% of the companies<br />
with which we maintain such business relations have<br />
an investment grade rating of “BBB” or better from Standard<br />
& Poor’s.<br />
Our business groups<br />
In the following sections we discuss the development of the<br />
financial year on the basis of our two strategic business<br />
groups, namely non-life reinsurance and life/health reinsurance.<br />
Supplementary to the information provided here, the<br />
segmental report contained in the annual financial statement<br />
shows the key balance sheet items and profit components broken<br />
down into the individual business groups.<br />
20 Management report OUR Business Groups<br />
<strong>Hannover</strong> <strong>Re</strong> Group annual report <strong>2010</strong>